The recent Madras High Court's (HC's) ruling in favour of the online pharmacy players will usher in the required validation and certainty to their business model, said industry players.
They are now awaiting discussions with the central government on the regulatory framework.
The Madras HC has reportedly set aside an earlier order by a single judge Bench asking them to stop engaging in the digital trade of medicines.
"There was a bit of uncertainty before, but with the draft rules being released, and now the favourable Madras HC order, the industry has received the validation it needed. It is unlikely that e-pharmacies will be barred from functioning," said a senior executive of an online pharmacy. The next step, industry executives say, is for the central government to put in place a proper regulatory framework for the sector to be monitored.
"This is going to give a lot of confidence to e-pharmacy companies to operate smoothly," said a top e-commerce executive.
Bu hikaye Business Standard dergisinin June 28, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin June 28, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Engagement speaks louder than followers
Actions, not followers, are new social currency for Indians online, reveals Comscore Social's mid-year review
Post-monsoon showers to be above-normal this year: IMD
The India Meteorological Department (IMD) on Tuesday said that after a strong rainy season, the post-monsoon months will also be good. It predicts rainfall across the country in October to be 'above normal' at 115 per cent of the Long Period Average (LPA). The cumulative all-India rainfall for October is around 75.4 mm.
Substandard drugs on a decline amid crackdown
The first of a two-part series focuses on how quality audits and regulatory actions on pharma units nationwide are showing results
CHANGING CHANNELS
Carmakers are adding layers to their dealerships to reach more buyers and meet rising aspirations, while increasing revenue per car. Do they have the right products?
Time for caution on Nifty, but no need to panic
Historic trend does not flag immediate concern even as monthly RSI stood at 83 in Sep, indicating 'overbought' condition: Analysts
Indices fall for third day on FII outflows
Benchmark indices Sensex and Nifty edged lower on Tuesday, extending the losing run to the third day amid profit-taking in oil & gas and select FMCG stocks.
Larger gold loan players less impacted by RBI advisory
The Reserve Bank of India (RBI) has issued an advisory for entities giving gold loans (GL) where it identified irregular practices and gave three months for lenders to correct these and avoid supervisory action.
Brokerages revise fee as true-to-label norms kick in
Leading brokerages have revised their charges with the true-to-label norms by the Securities and Exchange Board of India (Sebi) kicking in from Tuesday.
Allegations against Buch: Sebi board lacks power to act, experts point out
The Securities and Exchange Board of India (Sebi) board meeting on Monday was expected to address allegations of disclosure lapses and conflicts of interest involving Chairperson Madhabi Puri Buch. However, two board members disclosed that the matter was not brought up, leaving some participants disappointed, especially in light of a slew of accusations from the country's main Opposition party, the Congress.
Industry divided on T+O impact
The Securities and Exchange Board of India (Sebi) has announced a slew of measures to infuse life into the same-day (T+0) settlement cycle. However, market players are divided over their effectiveness given the lack of interest in the framework in the present form.
